Literature DB >> 332716

In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

J M Vierling, D L Nelson, W Strober, D M Bundy, E A Jones.   

Abstract

The in vitro cytotoxic function and target cell specificity of peripheral blood lymphocytes from selected patients with primary biliary cirrhosis and hepatitis B surface antigen-negative chronic hepatitis were investigated using 51Cr-labeled human Chang and EL-4 mouse sarcoma cell targets in assays of spontaneous cell-mediated cytotoxicity (SCMC) and mitogen-induced cellular cytotoxicity (MICC). In addition, antibody-dependent cellular cytotoxicity (ADCC) against Chang cells was assessed. At an effector-to-target cell ration of 100:1, the mean SCMC against Chang cells was much less in patients with primary biliary cirrhosis than that in either the controls (P less than 0.001) or the patients with chronic hepatitis (P less than 0.005) whereas the value for patients with chronic hepatitis did not differ significantly from that of the controls. The mean SCMC against EL-4 mouse sarcoma cells was also less in patients with primary biliary cirrhosis than in controls (P less than 0.005) whereas the value for chronic hepatitis was not significantly different from that of the controls or patients with primary biliary cirrhosis. In contrast, MICC against both targets and ADCC against Chang cells were similar for each group. Comparison of SCMC and MICC against both target cells, measured simultaneously, showed similar cytotoxic potenital against both target cells for each group. Effector cells capable of mediating cytotoxicity in each assay were defined by testing the cytotoxic function of lymphocyte subpopulations isolated from two representative patients with each disease using techniques of immunoabsorbent affinity chromatography and Fc receptor binding to antigen-antibody complexes. In both primary biliary cirrhosis and chronic hepatitis SCMC and ADCC were mediated by a subpopulation of lymphocytes which lack surface immunoglobulin (sIg-) and bear Fc receptors (Fc+). In contrast, MICC was mediated by sIg- cells which lack Fc receptors. Lymphocytes bearing sIg- were not cytotoxic in any assay. These results establish a difference in cytotoxic function in primary biliary cirrhosis and chronic hepatitis by defining the presence of a defect in spontaneous cytotoxic function of sIg-, Fc+ lymphocytes against Chang cells in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332716      PMCID: PMC372464          DOI: 10.1172/JCI108863

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  SEPARATION OF WHITE BLOOD CELLS.

Authors:  A BOYUM
Journal:  Nature       Date:  1964-11-21       Impact factor: 49.962

3.  Cell-mediated immune reactivity in liver disease.

Authors:  P A Bacon; H Berry; R Bown
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

4.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

5.  Coincidental Australia antigenemia in primary biliary cirrhosis.

Authors:  W C Maddrey; S Saito; N R Shulman; G Klatskin
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

6.  Australia antigen in chronic active liver disease with cirrhosis.

Authors:  G L Gitnick; G J Gleich; L J Schoenfield; A H Baggenstoss; A I Sutnick; B S Blumberg; W T London; W H Summerskill
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

7.  Impaired delayed hypersensitivity in primary biliary cirrhosis.

Authors:  S Sherlock; R A Fox; D G James; P J Scheuer; O Sharma
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

Review 8.  Immunopathology of viral hepatitis in man.

Authors:  W D Reed; A L Eddleston; R Williams
Journal:  Prog Med Virol       Date:  1974

9.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  17 in total

Review 1.  A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia.

Authors:  K Akahoshi; Y Miyata; M Hashimoto; S Koga; Y Chijiiwa; T Misawa; E Suematsu; J Nishimura; H Nawata
Journal:  Gastroenterol Jpn       Date:  1992-04

2.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Deficient natural killer cell activity in alcoholic cirrhosis.

Authors:  B Charpentier; D Franco; L Paci; M Charra; B Martin; D Vuitton; D Fries
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Lymphocyte cytotoxicity for autologous hepatocytes.

Authors:  M Mondelli; A L Eddleston
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

6.  Localisation of immunoglobulin on the liver cell surface in primary biliary cirrhosis.

Authors:  K Krogsgaard; U Tage-Jensen; P Wantzin; J Aldershvile; F Hardt
Journal:  J Clin Pathol       Date:  1981-10       Impact factor: 3.411

Review 7.  Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis.

Authors:  R J Klingenstein; J R Wands
Journal:  Springer Semin Immunopathol       Date:  1980-12

Review 8.  The role of liver membrane antigens as targets in autoimmune type liver disease.

Authors:  K H Meyer zum Büschenfelde; T H Hütteroth; M Manns; B Möller
Journal:  Springer Semin Immunopathol       Date:  1980-12

9.  Therapeutic quandary: asymptomatic primary biliary cirrhosis associated with polymyositis.

Authors:  R A Willson
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

10.  NK and K cell activity of human blood: differences according to sex, age, and disease.

Authors:  J Penschow; I R Mackay
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.